Commercial Drug Product Manufacturing and Commercialization Capability
We offer large-scale pharma commercial operations, including manufacturing and packaging of semi-solid creams and ointments as well as oral solid tablets and capsules, producing up to hundreds of millions of doses annually. UPM serves as a second-source supplier for several name brand, generic, nutraceutical and cosmetic products on the market today.
Our Facility: A Family-Pharma Legacy
Our 475,000 square-foot commercial manufacturing facility in Bristol, Tennessee, has been primarily owned and operated by the same family legacy for more than 25 years, with the exception of a three-year acquisition by Pfizer for commercial drug product manufacturing.
Supporting You At Every Stage
As an experienced commercial partner, UPM has time-tested procedures in place to optimize the commercial supply chain wherever you are in your journey. With this strong infrastructure, we can quickly devise the most efficient method to commercialize your product, quickly adjusting as necessary and making collaborative decisions that are truly in the best interest of your product and overall commercial drug manufacturing strategy.
From process development and validation to technology transfer and scale-up, we are able and eager to get your product to the patient at the end of the commercial supply chain. We invite you to visit our commercial drug product manufacturing facility, sit down with our leadership team, and ask the hard questions — an invitation that stands throughout the entirety of our journey together.